Teladoc (TDOC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Bullish comments from a noted short-seller pushed shares of Teladoc Health (TDOC 6.37%) higher on Friday. The telemedicine services company's stock peaked with a 15.2% jump at 10:20 a.m.
Teladoc Health (TDOC -5.79%) was a pandemic stock, meaning a company whose business was well-positioned to perform well during the worst of the coronavirus outbreak. Since it offers virtual health ser
In the latest trading session, Teladoc (TDOC) closed at $8.37, marking a +2.2% move from the previous day.
In the latest trading session, Teladoc (TDOC) closed at $7.87, marking a +2.61% move from the previous day.
In the closing of the recent trading day, Teladoc (TDOC) stood at $7.49, denoting a -3.97% move from the preceding trading day.

2 Beaten-Down Stocks to Avoid Right Now

09:30am, Friday, 05'th Sep 2025
Just because a stock has been battered doesn't make it an automatic buy. That's only the case if it can bounce back, and in some cases, there are few good reasons to believe it can.
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?

Teladoc: A Telehealth Titan in Trouble?

07:00pm, Monday, 25'th Aug 2025
Explore the exciting world of Teladoc (TDOC -0.13%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Teladoc Health remains a deep value play at $7, trading at just 5-6x EBITDA, but lacks a clear growth catalyst. Revenue and user metrics are declining across core segments, with BetterHelp and Chronic

Teladoc Health Earnings: Not Dead Yet

05:57am, Wednesday, 30'th Jul 2025
Teladoc's Q2 2025 earnings reaffirm strong free cash flow guidance, with the potential to reach $220 million in the next twelve months. Despite an attractive 7x next year's free cash flow valuation, r
Teladoc Health, Inc. Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Michael Minchak - Vice Preside
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE